fbpx MSSI Research Forum September 3 2015 | University of Limerick arrow
Search icon

MSSI Research Forum September 3 2015



Professor Rainer FischerPRESENTATION BY
Professor Rainer Fischer
Fraunhofer Institute for Molecular Biology, Aachen, Germany




The ability of German industry to compete on the international market depends to a large extent on the innovative power of its enterprises and its research organisations as well as their extensive global networks. With its clearly defined mission of application-oriented research and its focus on key technologies and solutions that are relevant to the future, the Fraunhofer Gesellschaft plays a prominent role in the German and European innovation process driven by applied research and development (R&D). The 67 Fraunhofer Institutes are continuously adapting their activities to meet current demand, thereby responding to the present and predicted needs of the market and its consumer. At the same time, they are contributing to the development of promising new technologies, platforms and product candidates through their own research and by supporting spin-off companies and in training highly skilled employees. This presentation addresses the role of R&D policy in the innovation strategy of the Fraunhofer Institute for Molecular Biology and Applied Ecology (Fraunhofer IME) by outlining recent innovation initiatives, networks and methods, giving practical examples from areas such as medical, pharmaceutical, plant and industrial biotechnology, all encompassed within the holistic discipline of systems biotechnology. We will emphasize common features of successful innovations and strategies to improve and accelerate innovation in the future. Finally we will consider the hurdles and stumbling blocks that prevent the conversion of innovations into real products, platform technologies or services, and strategies to improve the success rate at the interface of innovative applied R&D and industry on a national, European and global scale.  Selected examples of successful product developments and launches will be demonstrated.

Prof. Dr. Rainer Fischer received his Ph.D. in Molecular Biology from the Eberhard-Karls Universität Tübingen in 1990. After a postdoctorate with Professor Dr. J. Shively at the Beckman Research Institute of the City of Hope National Medical Center in Duarte (California, USA) he joined Baxter Healthcare Corporation, Immunotherapy Division, Santa Ana (California, USA) as project and group leader. He returned to Germany in 1993 to start his own lab at the RWTH Aachen University.

At present Prof. Dr. Fischer is Professor for Molecular Biotechnology at the RWTH Aachen University and Senior Executive Director of the Fraunhofer Institute for Molecular Biology and Applied Ecology with locations in Aachen, Schmallenberg, Giessen, Münster, Germany. Prof. Fischer's expertise in molecular biotechnology includes the areas of genomics, proteomics, cellomics, protein engineering, molecular medicine, immunology, virology, plant biotechnology as well as the production and purification of recombinant proteins.

As head of the Institute for Molecular Biotechnology at the RWTH Aachen University he supervised more than 77 Bachelor-, 153 Master- and 90 PhD theses. Prof. Fischer has delivered over 370 scientific presentations around the globe, more than 750 Fraunhofer concept presentations and published over 285 peer-reviewed scientific publications. He has also co-authored 52 book chapters. Additionally, he holds 64 pending patent applications and 37 granted patents. His current H-index is 57 with an excess of 11.800 citations. Furthermore, he has contributed to establish five start-up companies and sits on multiple international advisory boards.

DATE:       Thursday, 3 September 2015
TIME:        15h00 - 16h00
DURATION: 1 hour
VENUE:    LG011, Kathleen Lonsdale Building


For further information, please contact:
Professor Tewfik Soulimane,
Tel. No: (061) 234133r
Email: tewfik.soulimane@ul.ie